INTRODUCTION
A common mechanism for signal transduction utilized by many agonists comprises three major components: (1) a specific cell-surface receptor, (2) a GTP-binding protein and (3) an effector system [1, 2] . Examples of different effector systems coupled to cell-surface receptors include phosphodiesterase, adenylate cyclase, phosphoinositidespecific phospholipase C (PI-PLC) and a second lipase, most probably phospholipase A2 [1] [2] [3] [4] [5] . A single agonist may bind to multiple receptor subtypes, generating different second messengers. Vasopressin is an example of such an agonist. In renal collecting-duct epithelium, vasopressin binds to V2 receptors, which are coupled to adenylate cyclase via an interaction with a stimulatory GTP-binding protein (Ge), resulting in an increase in water permeability [6] . Vascular smooth-muscle cells and rat liver exhibit vasopressin Vla receptors, which stimulate phosphoinositide hydrolysis by activating a PI-PLC, resulting in smooth-muscle contraction and gluconeogenesis, respectively [7] [8] [9] . The vasopressin receptors involved in corticotropin release in adenohypophysis are classified as Vlb [10] . V1 receptors in liver are also coupled in a negative manner to adenylate cyclase via interactions with an inhibitory GTP-binding protein (Gi) [11] . In smooth-muscle cells V1 receptors negatively modulate cyclic AMP and cyclic GMP accumulation, and activate PI-PLC without the involvement of G, [12, 13, 8] .
Although there is no evidence demonstrating a direct interaction between GTP-binding proteins and PI-PLC, it is generally accepted that a GTP-binding protein regulates PI-PLC in a manner analogous to adenylate cyclase. This is due to the observation that GTP and stable GTP analogues stimulate hydrolysis of polyphosphoinositides in permeabilized cells and cell membranes [14] [15] [16] [17] [18] . For the V1 receptor, the identity of the GTP-binding protein which couples to PI-PLC is unknown [19] [20] [21] . However, in neutrophils and mast cells, chemotactic factors such as the peptide fMet-Leu-Phe [19] [20] [21] . The GTP-binding protein solubilized with rat liver V1 receptors was insensitive to pertussis-toxin treatment [19] . We have recently described the solubilization of unliganded V1 receptors from rat liver membranes by using egg lysophosphatidylcholine [23] . Receptors solubilized with lysophosphatidylcholine exhibited saturation kinetics with [3H]AVP when binding was performed in the presence of phospholipid vesicles [23] . The Kd of vasopressin binding to receptors solubilized in the absence of ligand with lysophosphatidylcholine (0.6 nM) compared very well with the Kd of vasopressin for membrane receptors (0.8 nM) [23] and was 10-fold lower than the Kd reported for agonist-bound V1 receptors solubilized from rat liver membranes with the detergent CHAPS [21] . This clearly suggests that lysophosphatidylcholine-solubilized V1 binding sites were in the high-affinity state even in the absence of agonist occupancy before solubilization.
PI-PLC has been purified from cytosolic fractions derived from several tissues, including rat liver, sheep seminal vesicle, bovine platelets, bovine brain and guineapig uterus [24] [25] [26] [27] [28] [29] [30] . Hofmann & Majerus [25] first reported that at least two immunologically distinct forms of PI-PLC exist. It is now known that there are at least five distinct isoenzymes of PI-PLC, based on immunological properties, molecular mass and substrate preference [25, [27] [28] [29] [30] . All five enzymes will hydrolyse PtdIns, PtdlnsP and PtdInsP2 under appropriate conditions. At concentrations of Ca2l which mimic those in the resting cell (-100 nM), PtdInsP and PtdInsP2 were preferred substrates [27] [28] [29] [30] [31] . It is currently unknown what role cytosolic PI-PLC plays in signal transduction. The substrates for PI-PLC are part of the cell membrane; therefore it can be presumed that, when the enzymes are catalytically active, they are membrane-associated. Evidence that cytosolic enzymes are involved in receptormediated phosphoinositide hydrolysis is provided by the finding that membrane-associated PI-PLC is immunologically identical with the cytosolic enzyme [29, 32] . Further evidence was provided by the finding that cytosolic enzymes from platelets and brain are stimulated by stable GTP analogues, suggesting they are associated with a GTP-binding protein [33, 34] .
We have previously described the purification, characterization and molecular cloning of a PI-PLC from guinea-pig uterus [29, 35] , with properties similar to those of sheep seminal-vesicle PI-PLC I [25, 31] The TSK-4000 gel-filtration column was from Beckman. The antiserum against PI-PLC I was raised by using purified PI-PLC I from guinea-pig uterus as described previously [29] . Methods Rat liver plasma membranes were prepared and solubilized with egg lysophosphatidylcholine as described previously [23] . Vasopressin-binding assays were done in triplicate by mixing solubilized preparation with phospholipid (asolectin) (7.5 %, w/v) in 1:1 ratio and then incubating with [3H]AVP in the absence (total) or presence (non-specific) of 5,uM-AVP (unlabelled) for 60 min at 30 'C. After incubation the reaction was stopped by addition of 4 ml of ice-cold buffer A (10 mmNa-Hepes, pH 7.4, 2 mM-MgCl2 and 0.1 % bovine serum albumin). The free ligand was separated from the bound ligand by filtration through GF/B glass-fibre filters (presoaked in 1 % polyethyleneimine) [36] . The initial filtration was followed by two 5 ml washes with buffer A. The filtration was performed on a 24-sample cell harvester (Brandel). Non-specific binding was [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] 30 "C, samples were diluted with 4 ml of incubation buffer and filtered on nitrocellulose filters. The filters were washed with 3 x 2 ml of buffer, dried and counted for radioactivity in a fl-scintillation counter. Specific binding was 75-80 % of total binding.
Protein measurement
This was done by the Pierce bicinchoninic acid (BCA) protein assay (Pierce Chemical Co.). Chromatographic separation of the lysophosphatidylcholine-solubilized rat liver plasma membranes Lysophosphatidylcholine-solubilized rat liver membrane fraction was chromatographed on a DEAESepharose column (3 cm x 9 cm). The column was equilibrated with buffer B, containing 20 mM-Na-Hepes (pH 7.4), 5 mM-MgCl2 and 0.02 % egg lysophosphatidylcholine. The column was washed with equilibration buffer (30 ml) and then eluted with a 125 ml gradient of NaCl ( Protein from each fraction was resolved on a SDS/10 % polyacrylamide gel. Adjacent lanes of the gel contained known amounts of purified guinea-pig uterus PI-PLC I (100 ng-I ,tg). Proteins were transferred to nitrocellulose paper, and probed with anti-PI-PLC I antibodies, followed by 125I-labelled goat anti-rabbit IgG as previously described [29] . After autoradiography the quantity of PI-PLC I was estimated in each fraction by scanning densitometry (LKB, Uppsala, Sweden). The assays were linear between 100 ng and 1 ,ug of protein.
Immunoaffinity absorption
IgG was purified from immune and preimmune serum by affinity chromatography on Protein A columns (Beckman, Palo Alto, CA, U.S.A.). The IgG was covalently coupled to CNBr-activated Sepharose-4B (Pharmacia). The final yield was 2.3 mg of protein/ml of gel. Solubilized rat liver membranes (1.6 mg of protein)
were incubated with 2.0 ml of either preimmuneIgG-Sepharose or immune-IgG-Sepharose for 16 h at 4 'C. The column was washed with buffer B to remove unbound protein. Total [3H]AVP-binding activity in the flow-through fractions was measured as described above.
RESULTS
We have previously demonstrated that the rat liver vasopressin receptors were effectively solubilized with egg lysophosphatidylcholine [23] . suggests that the G-protein involved is not Gi/Go or Gs, and confirms the observation in membranes [19] . Previous studies have shown that vasopressin receptors are coupled to a PI-PLC through a cholera-toxin/ pertussis-toxin-insensitive G-protein. To determine if vasopressin receptors were coupled to a PI-PLC in the solubilized fractions, it was first necessary to establish conditions for the enzyme assay which would permit Pl-PLC to hydrolyse [3H]PtdInsP2 in the presence of the egg lysophosphatidylcholine used to solubilize the membranes. It was necessary to include a 10-fold molar excess of phosphatidylethanolamine and at least 0.30 cholate in the assays to detect PI-PLC enzyme activity in the solubilized fractions. Under these assay conditions rat liver membranes exhibited PI-PLC activity of 23.0 pmol/ min per mg with 20 /iM-[3H]PtdInsP2 as substrate, and the solubilized fractions exhibited a specific activity of 58.9 pmol/min per mg (Table 2) . Therefore the conditions used to solubilize vasopressin receptors selectively [23] resulted in a 2.5-fold enrichment of PI-PLC enzyme activity. Both G-protein binding activity and PI-PLC in rat liver membranes and solubilized membrane fraction are in excess compared with vasopressin binding (Table  2) . Numerous attempts to measure either a GTP[S]-or a vasopressin-stimulated PI-PLC activity under various assay conditions, including varying free Ca2+ concentrations from 65 nm to 100 UM, were unsuccessful.
Thus the conditions required for detection of PI-PLC enzyme activity with exogenous substrate could dissociate PI-PLC from the receptor. Alternatively, PI-PLC may not be associated with the receptor under these solubilization conditions.
To address this question further, we utilized antibodies specific for a PI-PLC isoenzyme, PI-PLC I [29] , to immunoprecipitate [3H]AVP-binding activity from the solubilized liver membranes. To demonstrate that antibodies prepared against guinea-pig uterus PI-PLC I would cross-react with a similar enzyme in rat liver membranes, we performed immunoblot analysis of various rat liver subcellular fractions (Fig. 3) . Anti-PI-PLC I antibodies recognized a 60 kDa protein in rat liver cytosol (Fig. 3, lane 2) , rat liver membranes (Fig. 3, lane  3 ) and solubilized rat liver membranes (Fig. 3, lane 4) . Consistent with the observations on enzyme activity, there was an enrichment of PI-PLC I in the solubilized fraction compared with membranes (Fig. 3, lanes 3 and  4) . The PI-PLC I in rat liver co-migrated with purified guinea-pig uterus PI-PLC I (Fig. 3, lane 1) . Preimmune immunoglobulins failed to react with proteins in any of the fractions (Fig 3b) (Fig. 4) . Fig. 3 . Identification of PI-PLC I in rat liver membrane fractions Samples were separated by SDS/PAGE (10% gel), electrophoretically transferred to nitrocellulose paper, and probed with either PI-PLC I antibodies (a) or preimmune antibodies (b), followed by 1251I-Protein A [28] . Lanes: (1) 0.25 ,g of purified guineapig uterus PI-PLC I, (2) 100 g of rat liver cytosolic proteins, (3) 100 jig of rat liver membrane proteins, (4) 100 ,tg of solubilized rat liver membranes, (5) 100,sg of hog kidney cytosolic proteins, (6) 100 jig of hog kidney membrane proteins, and (7) of three GTP[S]-binding-activity peaks (Fig. 5b) . PI-PLC enzyme activity migrated as one major peak of approx. 240 kDa, with a minor peak of activity present in the void volume (Fig. Sb) . Immunoblots with anti-PI-PLC I antibody demonstrated a good correlation between PI-PLC enzyme activity and PI-PLC I immunoreactivity (results not shown). Rat liver cytosolic proteins were separated by gel-filtration h.p.l.c. under identical conditions and analysed for PI-PLC I immunoreactivity. Cytosolic PI-PLC I exhibited an apparent molecular mass of 60 kDa, which is in agreement with that reported for guinea-pig-uterus cytosolic PI-PLC I [29] . These data suggest that the major [3H]AVP-binding activity peak eluted at 240 kDa may be a complex of vasopressin receptor, G-protein and PI-PLC I.
To rule out the possibility that [3H]AVP-binding sites were forming a non-specific precipitate after incubation with anti-PI-PLC I antibodies and Protein A-Sepharose, the fractions containing [3H]AVP-binding activity from the gel-filtration chromatography were pooled and then applied to either an anti-PI-PLC I IgG immunoaffinity column or to a preimmune-IgG affinity column.
[3H]AVP-binding activity in the flow-through fractions was determined. The anti-PI-PLC I IgG affinity column retained 50-60 % of the total [3H]AVP-binding activity, whereas the preimmune-IgG column retained less than 10 % of the binding activity (Table 3 ). Attempts to elute [3H]AVP-binding activity from the antibody columns were not successful, probably owing to the harsh conditions required. These observations strongly suggest that solubilization of rat liver membranes with egg lysophosphatidylcholine results in a complex of receptor, G-protein and PI-PLC.
DISCUSSION
Studies from a number of laboratories have shown that vasopressin V1 receptors in hepatocytes and smooth muscle are coupled to phospholipase C through a Gprotein which is insensitive to both cholera toxin and pertussis toxin [8, 9] . The key finding in the present paper is that, in the absence of agonist occupancy, a portion of the vasopressin V1 receptors from rat liver membranes is solubilized as a complex containing the receptor. GTPbinding protein and PI-PLC I. The co-solubilization of a G-protein along with the vasopressin receptors is documented by (a) high-affinity agonist binding to the sotubilized fractions, (b) inhibition ofvasopressin binding by GTP and its stable analogues and (c) stimulation of GTP[35S] binding by AVP. The co-solubilization of receptor with G-protein(s) is in agreement with those studies on the solubilization of dopamine D1 [41] and adenosine A1 [42] receptors, and in contrast with what has been observed with ,- [43] and a2- [44] adrenergic and dopamine D2 [45] receptors, where high-affinity binding as well as the guanine-nucleotide sensitivity were lost once the receptors were solubilized. It is noteworthy that all the above receptors except vasopressin are coupled to adenylate cyclase, whereas V1 receptors are coupled to PI-PLC.
The present study also suggests the presence of PT-PLC in the solubilized fraction as demonstrated by enzymic and immunoblot analyses. The enzyme PI-PLC is found in both cytosolic and membrane fractions. In rat liver, over 50 % of total cellular PI-PLC was found to be membrane-associated. During chromatographic fractionation, the major vasopressin-binding activity was co-eluted with PI-PLC and G-protein(s).
Although we demonstrated that anti-PI-PLC I antibodies immunoprecipitated [3H]AVP-binding activity from solubilized rat liver membranes, we were unable to demonstrate an AVP-or guanine-nucleotide-dependent stimulation of PI-PLC enzyme activity in the solubilized membranes. One explanation for the lack of AVP stimulation of PI-PLC enzyme activity may be that PI-PLC was solubilized in a complex precoupled to the receptor and G-protein, and therefore further activation by agonist was not possible. Alternatively, the G-protein may exert a negative effect on PI-PLC enzyme activity which is relieved by coupling ofagonist-occupied receptor to the GTP-binding protein, or by binding of GTP analogues to the G-protein [46] . The use of cholate in the enzyme assays may also relieve the negative effects of the GTP-binding protein, resulting in full activation of the enzyme. Cholate may also dissociate PI-PLC from the G-protein so that agonist-dependent activation of the enzyme was no longer possible. In addition, conditions which were optimal for measurement of PI-PLC activity (Fig. 5b) . Therefore it may not be possible to detect a 5 increase in PI-PLC activity under the current assay conditions. There are at least five distinct PI-PLC isoenzymes in mammalian tissues [25, [27] [28] [29] . These enzymes exhibit different molecular masses on SDS/PAGE, differ in antigenic properties, and more recently have been demonstrated to have different amino acid sequences [25, [27] [28] [29] 35, [47] [48] [49] [50] . It [25, 28, 51] .
In summary, we have presented data which for the first time describes the solubilization of a cell-surface receptor (V1) as a complex with the coupler (G-protein) and effector (PI-PLC).
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